Vaxcyte, Inc. (PCVX)
58.71
-1.01
(-1.69%)
USD |
NASDAQ |
Apr 28, 16:00
58.71
0.00 (0.00%)
After-Hours: 19:43
Vaxcyte Total Assets (Quarterly) : 3.046B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 582.98M |
| Corcept Therapeutics, Inc. | 838.03M |
| Cytokinetics, Inc. | 1.425B |
| Syndax Pharmaceuticals, Inc. | 529.71M |
| Cogent Biosciences, Inc. | 937.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 360.46M |
| Shareholders Equity (Quarterly) | 2.686B |
| Debt to Equity Ratio | 0.0437 |
| Current Ratio | 7.909 |
| Net Debt Paydown Yield | -0.30% |